2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Gray Zone Lymphoma: new trials by email Literature Review of Gray Zone Lymphoma trials Research Report on Gray Zone Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine Bendamustine, Cyclophosphamide - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1 | Completed | University of Arizona | 50 | 2016-11-29 | 2025-11-10 |
| Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma CPX-351 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 27 | 2013-09-01 | 2020-11-09 |
Burkitt Lymphoma (2) · Hodgkin Disease (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Mycobacterium avium-intracellulare Infection (1)
DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoma, B-Cell (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Bendamustine Hydrochloride (1) · CPX-351 (1) · Cyclophosphamide (1)
Children's Hospital Medical Center, Cincinnati (1) · University of Arizona (1)
United States (2)
Emmanuel Katsanis, MD (1) · John Perentesis, MD (1)
PMID 29908231, PMID 32582591, PMID 35460929, PMID 35847727, PMID 40270968